PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel therapy for pet cats with head and neck cancers could help humans, too

2025-08-28
(Press-News.org) Researchers have reported results from the first-ever clinical trial of a new class of targeted therapy in pet cats with head and neck squamous cell carcinoma (HNSCC)—a cancer which is notoriously deadly and difficult to treat. Publishing in the Cell Press journal Cancer Cell on August 28, the study found that 35% of the cats who received treatment had their disease controlled with minimal side effects—and the drug will likely be effective for humans with HNSCC as well. 

“There are two major findings from this study,” says senior author Daniel Johnson of the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center. “It showed us that it’s possible to target a transcription factor that drives oncogenesis, which is something that has been notoriously difficult in the past. Also, it demonstrated that pets with cancer can be a good representation of human disease and that clinical trials in pets may yield more reliable results than tests in mouse models.” 

This drug, which was initially conceptualized to treat human head and neck cancers, is the first to target the transcription factor STAT3. STAT3 is present in a range of both solid and liquid tumors, including a majority of HNSCC cases. 

The idea to test the HNSCC drug on pet cats came from a discussion first author Jennifer Grandis had with her sister, a veterinarian. Grandis learned that oral cancers like HNSCC in pet cats are extremely difficult to treat and that most animals die within 2 to 3 months of diagnosis.  

“There is remarkable clinical, histopathologic, and immunologic similarity between feline and human HNSCC,” the authors write. 

One cat who benefited from the trial was a 9-year-old black domestic shorthair named Jak. When he was diagnosed with HNSCC, the veterinarian gave him only 6 to 8 weeks to live.  

“It was just a gut punch,” says his owner, Tina Thomas. “We wanted more time with him. When I found out about this clinical trial, I knew I wanted him to be a part of it.” 

Jak went for weekly treatments for one month. During that time his symptoms—mainly, a watery eye—greatly improved. He ultimately lived more than 8 months after his diagnosis. 

“It was meaningful to us because he was here in our lives,” says Thomas. “During that time, my son finished college and my daughter finished her master’s program. Jak got to spend one more Christmas with us, and he loved our Christmas tree. He was worth every bit of the effort.” 

Other than mild anemia, none of the cats in the trial developed side effects that were attributable to the treatment. Of the 20 cats that were enrolled, 7 of them exhibited either a partial response or stable disease during the study period. Among the 7 that responded, the average survival post-treatment was 161 days. 

When the investigators looked at tumors and blood samples from the cats who underwent treatment, they saw that the compound was working in two ways: It not only blocked the activity of STAT3 but it also raised levels of PD-1, a protein associated with an immune response to cancer. 

“This study is a great example of how we can think more carefully about spending our very limited resources on studies in lab mice that are not even the best models of human cancers,” Grandis says. “By partnering with veterinary oncologists and doing clinical trials in companion animals, we can learn an enormous amount about how these drugs work while also helping people’s pets. None of the cats in these trials were harmed, and many of them benefited.” 

The researchers say that conducting clinical trials in pets can be a much better model of how drugs will work in humans compared with lab mice. They are currently working with a small biotech company to advance the new compound in clinical trials for both pets and humans. 

“These animals breathe the same air that we breathe and are exposed to all the things we’re exposed to,” says Johnson. “Their tumors are much more heterogeneous, which makes them a better mimic of human disease.”

### 

This work was supported by the National Institutes of Health and the Center for Companion Animal Health at the University of California Davis. 

Cancer Cell, Grandis et al., Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer” https://www.cell.com/cancer-cell/fulltext/S1535-6108(25)00321-6

Cancer Cell (@Cancer_Cell), published by Cell Press, is a monthly journal that provides a high-profile forum to promote major advances in cancer research and oncology. The journal covers topics related to molecular and cellular mechanisms of cancer, mechanisms for the sensitivity and the resistance to cancer therapies, development of better cancer therapies, and clinical investigations. Visit: http://www.cell.com/cancer-cell. To receive Cell Press media alerts, contact press@cell.com. 

END



ELSE PRESS RELEASES FROM THIS DATE:

Researchers develop novel treatment for central nervous system injury

2025-08-28
Traumatic injuries of the central nervous system (CNS)—such as traumatic brain injury (TBI) and traumatic spinal cord injury (SCI)—are characterized by oxidative damage and neuroinflammation. Current treatment relies mainly on supportive care and surgical intervention, with a lack of effective drugs to directly target the underlying damage. For example, neural stem cell (NSC)-based therapy has shown therapeutic potential, but pathological microenvironments negatively impact NSC survival and directed differentiation, compromising therapeutic outcomes. Similarly, antioxidant treatment ...

Debt, bankruptcy, and credit scores after cancer diagnosis

2025-08-28
About The Study: In this retrospective cohort study, modest amounts of medical debt in collections persisted for years after cancer diagnosis. Total debt in collections was present at higher amounts for certain cancer subpopulations. The persistence of adverse financial outcomes after cancer diagnosis, despite high rates of insurance coverage in Massachusetts, warrants further research and consideration of broader systemic reforms. Corresponding Author: To contact the corresponding author, Benjamin C. James, MD, MS, email bjames1@bidmc.harvard.edu. To ...

Glucagon-like peptide-1 receptor agonists and risk of uveitis

2025-08-28
About The Study: This cohort study found that glucagon-like peptide-1 receptor agonist (GLP-1RA) prescriptions were associated with a lower risk of uveitis compared with controls. These findings suggest potential anti-inflammatory benefits beyond glycemic control, warranting further investigation into their role in ocular inflammatory diseases. Corresponding Author: To contact the corresponding author, Sumit Sharma, MD, email sumitsharma.md@gmail.com. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaophthalmol.2025.2822) Editor’s Note: Please see the article for additional ...

Study proposes new, more personalized methadone restart approach for opioid use disorder

2025-08-28
AURORA, Colo. (August 28, 2025) – A new study from University of Colorado Anschutz and Denver Health researchers, published today in JAMA Network Open, introduces a more individualized approach to restarting methadone treatment for people with opioid use disorder. The findings suggest that tailoring methadone doses to each patient’s unique circumstances can improve care without compromising safety. Methadone is a proven medication that can cut the risk of death from opioid use disorder by about 50%. The researchers considered that current treatment protocols ...

Majority of oncology staff at Moroccan Cancer Institute affected by burnout

2025-08-28
“Burnout is highly prevalent among oncology healthcare professionals in Morocco, particularly among young female nurses.” BUFFALO, NY — August 28, 2025 — A new research paper was published in Volume 12 of Oncoscience on July 31, 2025, titled “Burnout among oncology nurses and technicians in Morocco: Prevalence, risk factors, and structural equation modeling.” In this study, Imane Errami, Saber Boutayeb, and Hassan Errihani from the Faculty of Medicine and Pharmacy at University Mohammed V of Rabat investigated ...

People who skip breakfast and eat late dinners may have a higher risk of osteoporosis

2025-08-28
WASHINGTON—People who skip breakfast and eat late dinners may have an increased risk of developing osteoporosis, according to a new study published in the Journal of the Endocrine Society. Lifestyle habits, such as exercise, alcohol consumption and smoking, are known to increase people’s risk of osteoporosis, however little is known about the association between osteoporotic fracture and diet. “This study aimed to examine the association between lifestyle habits such as diet, and the risk of osteoporotic fracture,” ...

Pertussis resurgence in Tuscany outlines importance of timely vaccination in Italy

2025-08-28
Pertussis, commonly known as whooping cough, is a vaccine-preventable disease which continues to circulate even in areas where vaccination coverage is high, and outbreaks may still occur. A study published in Eurosurveillance and conducted at Meyer Children’s Hospital in Florence, Italy, has found a sharp increase in hospitalisations for pertussis among children and adolescents (patients aged 16 years or under) in 2024. The findings highlight the critical role of not only adhering to vaccination schedules but also administering doses at the earliest opportunity to ensure a further reduction in cases and hospitalisations ...

Innovative food processing technologies: a path to nutritional efficiency in staple crops

2025-08-28
In a world where the demand for healthier diets is on the rise, a new review published in Engineering explores how innovative food processing technologies can enhance the utilization of nutrients in staple food crops. The study, titled "Innovative Food Processing Technologies Promoting Efficient Utilization of Nutrients in Staple Food Crops," delves into the challenges of traditional food processing methods and highlights the potential of modern techniques to improve nutritional profiles ...

We must develop thinkers, not crammers and fact experts

2025-08-28
Hilde Storrøsæter is worried about the teaching of geography in schools. Geography as a school subject is under pressure. There aren't enough qualified teachers and it loses out to other subjects in school. In many countries, important aspects are left out of the geography curricula.  "Alarm bells should be ringing, both in the field and among teachers in schools. The development we are seeing in geography as a subject is critical. This failure affects the students' ability to understand how things are connected in a troubled and confusing world," she said. Storrøsæter is a geographer and assistant professor at the Norwegian University ...

Political polar opposites may be more alike than they think

2025-08-28
The brains of politically extreme individuals, whether left- or right-leaning, appear to respond to and process political information in surprisingly similar ways, according to research published by the American Psychological Association. “Both extreme liberals and extreme conservatives consumed the same political content, and even though they held vastly different beliefs, their brains appeared to process the information in a very similar manner,” said Oriel FeldmanHall, PhD, a professor of cognitive and psychological sciences at Brown University and co-author of the study, published in the Journal of Personality and Social Psychology. “In contrast, ...

LAST 30 PRESS RELEASES:

Artificial tongue uses milk to determine heat level in spicy foods

IU Kelley Futurecast: AI and energy infrastructure may buoy US economy in 2026

The biggest threats to maintaining fat bike trails: climate change and volunteer burnout

AI models for drug design fail in physics

Practice pattern of aerosol drug therapy in acute respiratory distress syndrome patients: An aero-in-ICU study

GLIS model as a predictor of outcomes in older adults with heart failure

Molecules in motion: pioneering the era of supramolecular robotics

Faster and more reliable crystal structure prediction of organic molecules

Thankful at work: A two-week gratitude journal boosts employee engagement

Fibroblasts: Hidden drivers of heart failure progression

IOCB Prague unveils a fundamentally faster, more affordable way to produce quantum nanodiamonds

Artificial intelligence takes the lead in revolutionizing cancer research explored at NFCR’s 2025 Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship.

Switching memories on and off with epigenetics

This is your brain without sleep

3D DNA looping discovery in rice paves the way for higher yields with less fertilizer

Four subgroups of PCOS open up for individualized treatment

Perovskites reveal ultrafast quantum light in new study

New clues on how physical forces spread in neurons

Heart ‘blueprint’ reveals origins of defects and insights into fetal development

Some acute and chronic viral infections may increase the risk of cardiovascular disease

Flavanols in cocoa can protect blood vessel function following uninterrupted sitting - study

$100 Million gift will advance UCSF’s dementia research and care

The 4th Japan-India Universities Forum on 15 November

Arctic town Kiruna is colder after the move

Mayo Clinic study finds majority of midlife women with menopause symptoms do not seek care

Underwater robot ‘Lassie’ discovers remarkable icefish nests during search for Shackleton’s lost ship off Antarctica

Wearable robots you can wear like clothes: automatic weaving of “fabric muscle” brings commercialization closer

Researcher improves century-old equation to predict movement of dangerous air pollutants.

Heatwaves linked to rise in sleep apnoea cases in Europe

Down‑top strategy engineered large‑scale fluorographene/PBO nanofibers composite papers with excellent wave‑transparent performance and thermal conductivity

[Press-News.org] Novel therapy for pet cats with head and neck cancers could help humans, too